Suppr超能文献

[病例报告——口服优福定与伊立替康、氟尿嘧啶、亚叶酸钙经肝动脉灌注联合化疗治疗乙状结肠癌多发肝转移]

[A case report--combination chemotherapy with oral UFT and CPT-11, 5-FU, l-LV by hepatic arterial infusion for multiple hepatic metastasis from sigmoid colon cancer].

作者信息

Kubo Hidefumi, Kanekiyo Shinsuke, Watanabe Yusaku, Tada Kosuke, Hasegawa Hiroyasu

机构信息

Dept. of Surgery, Tokuyama Central Hospital.

出版信息

Gan To Kagaku Ryoho. 2007 Dec;34(13):2313-6.

Abstract

A 64-year-old woman was diagnosed with multiple hepatic metastases from sigmoid colon cancer. She underwent resection of the colon and catheter insertion into the hepatic artery for arterial infusion in August 2006. She was then treated with postoperative combination chemotherapy consisting of UFT and CPT-11, 5-FU, l-LV. UFT was administered orally at 400 mg/body/day every day and CPT-11 was injected at 100 mg/body/week, 5-FU at 750 mg/body/week, and l-LV at 300 mg/body/week for 8 continuous weeks. After 2 months of the chemotherapy, the metastatic liver tumors disappeared. So hepatic arterial infusion with the same regimens was injected once every month 4 more times. Oral UFT was administered every day. After 6 months of the combined chemotherapy above, we judged the effects of the chemotherapy to be a complete response. Then the chemotherapy was followed by oral UFT only. As severe nausea and vomiting were seen in this patient with an initial dose of 150 mg/body/week of CPT-11 at first, we reduced the dose of CPT-11 to 100 mg/body/week. From then, outpatient care was possible because no severe events were observed. Combined chemotherapy consisting of oral UFT and CPT-11, 5-FU and l-LV by hepatic arterial infusion is suggested to be a new and effective treatment for multiple liver metastases from colorectal cancer.

摘要

一名64岁女性被诊断为乙状结肠癌多发肝转移。2006年8月,她接受了结肠切除术并经肝动脉插管进行动脉灌注。随后,她接受了由优福定(UFT)、伊立替康(CPT - 11)、5 - 氟尿嘧啶(5 - FU)和亚叶酸钙(l - LV)组成的术后联合化疗。优福定每天口服,剂量为400mg/人/天;伊立替康每周注射,剂量为100mg/人;5 - 氟尿嘧啶每周剂量为750mg/人,亚叶酸钙每周剂量为300mg/人,持续8周。化疗2个月后,肝脏转移瘤消失。此后,按照相同方案每月进行1次肝动脉灌注,共进行4次。优福定继续每日口服。经过上述联合化疗6个月后,我们判断化疗效果为完全缓解。之后仅口服优福定维持化疗。由于该患者最初使用伊立替康剂量为150mg/人/周时出现严重恶心和呕吐,我们将伊立替康剂量减至100mg/人/周。从那时起,由于未观察到严重事件,患者可以门诊治疗。由口服优福定、伊立替康、5 - 氟尿嘧啶和肝动脉灌注亚叶酸钙组成的联合化疗被认为是治疗结直肠癌多发肝转移的一种新的有效方法。

相似文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验